Legal Representation
Attorney
David L. Sigalow
USPTO Deadlines
Application History
18 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Sep 8, 2014 | MAB6 | O | ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED | Loading... |
| Sep 8, 2014 | ABN6 | S | ABANDONMENT - NO USE STATEMENT FILED | Loading... |
| Feb 4, 2014 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
| Dec 10, 2013 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Dec 10, 2013 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Nov 20, 2013 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Nov 5, 2013 | PREV | O | LAW OFFICE PUBLICATION REVIEW COMPLETED | Loading... |
| Oct 31, 2013 | ALIE | A | ASSIGNED TO LIE | Loading... |
| Oct 17, 2013 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Oct 11, 2013 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Oct 11, 2013 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Oct 11, 2013 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Jul 23, 2013 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Jul 23, 2013 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
| Jul 23, 2013 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Jul 16, 2013 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Apr 8, 2013 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Apr 5, 2013 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 005
Pharmaceutical preparations for the treatment of gastrointestinal, cardiovascular, metabolic, sleep disorders and central nervous systems disorders; vitamins; nutritional supplements; medicinal food preparations, namely, capsules and sachets comprising multiparticulates containing terpine for use in the management of gastrointestinal, cardiovascular, metabolic, sleep disorders and central nervous systems disorders; components of pharmaceutical preparations containing melatonin and a buffer for the management of gastrointestinal, cardiovascular, metabolic, sleep disorders and central nervous disorders; vitamins and nutritional supplements for use in the fields of gastrointestinal, cardiovascular, metabolic, sleep disorders and central nervous system disorders
First Use Anywhere:
0
First Use in Commerce:
0
Classification
International Classes
005